Hossein Rajabi
Associate Professor
Speciality: Medical Physics (Nuclear Medicine)
  • BS/BA: Physics
  • MS: Medical Physic
  • PhD: Medical Physic
  • Phone: 82883894
  • Fax:
  • Email: hrajabi@modares.ac.ir
  • Address: School of Medical Sciences, Tarbiat Modares University
  • Resume Download
 

 

1. Parach AA, H. HR. A comparison between GATE4 results and MCNP4B published data for internal radiation dosimetry. Nuklearmedizin. 2011 Mar;50(3):122-33.
2. Parach AA, Rajabi H, Askari MA. Assessment of MIRD data for internal dosimetry using the GATE Monte Carlo code. Radiat Environ Biophys. 2011 Aug;50(3):441-50.
3. Zaknun JJ, Rajabi H, Piepsz A, Roca I, Dondi M. The International Atomic Energy Agency software package for the analysis of scintigraphic renal dynamic studies: a tool for the clinician, teacher, and researcher. Semin Nucl Med. 2011 Jan;41(1):73-80.
4. Salouti M, Babaei MH, Rajabi H, Foroutan H, Rasaee MJ, Rajabi AB, et al. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging. Ann Nucl Med. 2011 Feb;25(2):87-92.
5. Rasaneh S, Rajabi H, HBabaei M, Johari-Daha F. Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines. Appl Radiat Isot. 2010 Oct;68(10):1964-6.
6. Rasaneh S, Rajabi H, Babaei MH, Daha FJ. 177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer. Nucl Med Biol. 2010 Nov;37(8):949-55.
7. Raeisi E, Firoozabadi SM, Hajizadeh S, Rajabi H, Hassan ZM. The effect of high-frequency electric pulses on tumor blood flow in vivo. J Membr Biol. 2010 Jul;236(1):163-6.
8. Rasaneh S, Rajabi H, HBabaei M, Johari-Daha F. Synthesis and biodistribution studiesof 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model. J LABELLED COMPD RAD. 2010 Jul;53(6):575-9.
9. Shalchian B, Rajabi H, Soltanian-Zadeh H. Fusion of PET and CT images using wavelet transform. Hell J Nucl Med. 2009 Sep;12(3):238-43.
10. Rasaneh S, Rajabi H, Babaei MH, Daha FJ, Salouti M. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer. Nucl Med Biol 2009 May;36(4):363-9.
11. Shalchian B, Rajabi H, Soltanian-Zadeh H. Assessment of the Wavelet Transform in Reduction of Noise from Simulated PET J Nucl Med Technol. 2009 Dec;37(4):223-8.
12. Bitarafan-Rajabi A, Rajabi H, Rastgou F, Sharafi AA. Effect of respiratory motion on quantitative myocardial gated SPECT: a simulation study. Ann Nucl Med. 2009 Aug;23(6):587-93.
13. Salouti M, Rajabi H, Babaei MH, Rasaee MJ. Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical. Nucl Med Biol. 2008 Oct;35(7):763-8.
14. Bitarafan A, Rajabi H. The effect of filtrating and reconstruction method on the left ventricular ejection fraction derived from GSPET: a statistical comparison of angiography and echocardiography. Ann Nucl Med. 2008 Oct;22(8):707-13.
15. Kalantari F, Rajabi H, Yaghoobi N. Optimized energy window configuration for 201Tl imaging. J Nucl Med Technol. 2008 Mar;36(1):36-43.
16. Bitarafan A, Rajabi H, Gruy B, Rustgou F, Sharafi AA, Firoozabady H, et al. Respiratory motion detection and correction in ECG-gated SPECT: a new approach. Korean J Radiol. 2008 Dec;9(6):490-7.
17. Raeisi E, Rajabi H, Aghamiri SMR. A new approach for quantitative evaluation of reconstruction algorithm. Iranian Journal of Radiation Research. 2007 Sep;4(2):77-80.
18. Salouti M, RajabiI H, Babaei MH, Rasaee MJ, Najafi R, Paknejad M, et al. A new monoclonal antibody radiopharmaceutical for radioimmunoscintigraphy of breast cancer: direct labeling of antibody and its quality control. Daru. 2006 Mar;14(1):51-6.
19. Rasaneh S, Rajabi H, Hajizade E. Alternative methods for evaluation of non-uniformity in nuclear medicine images. I J Rad Res. 2005 Sep;3(2):89-94.
20. Rajabi H, Bitarafan A, Yaghoobi N, Firouzabadi H, Rustgou F. Determination of the Optimum Filter Function for Tc99m- -Sastamibi Myocardial Perfusion SPECT Imaging. IJNM. 2005;20(3):77-83.
21. Rajabi H, Pant GS, Padhy AK. Renal Transit times usinh modified method of deconvolutionne. IJNM. 2003;18(1):37-43.
22. Rajabi H, Pant GS, Padhy AK. Physical Validation of deconvolution software. IJNM. 2002;17(1):30-4.
23. Rajabi H, pant GS. Optimum filtration for time activity curve in nuclear medicine. Nucl Med Commun. 2000 Sep;21(9):823-9.
24. Rajabi H, Pant. GS. Optimum filtration for time-activity curves in nuclear medicine. Nucl Med Commun. 2000 Sep;21(9):823-8.
25. Rajabi H, Pant GS. An algorithm for filtration of time activity curve. I Med Phys. 2000 Apr;25(2):75-8.
26. Rajabi H, Pant GS. Evaluation of transit time by deconvolution analysis in a radionuclide renogram. J Med Phys. 1997 Dec;22(4):178-81.
27. Goliaei B, Rajabi H, Rabbani A. Effects of hyperthermia on the colony-stimulating factor production by the lung. Int J Radiat Oncol Biol Phys. 1992;22(5):1029-33.
1. Parach AA, H. HR. A comparison between GATE4 results and MCNP4B published data for internal radiation dosimetry. Nuklearmedizin. 2011 Mar;50(3):122-33.
2. Parach AA, Rajabi H, Askari MA. Assessment of MIRD data for internal dosimetry using the GATE Monte Carlo code. Radiat Environ Biophys. 2011 Aug;50(3):441-50.
3. Zaknun JJ, Rajabi H, Piepsz A, Roca I, Dondi M. The International Atomic Energy Agency software package for the analysis of scintigraphic renal dynamic studies: a tool for the clinician, teacher, and researcher. Semin Nucl Med. 2011 Jan;41(1):73-80.
4. Salouti M, Babaei MH, Rajabi H, Foroutan H, Rasaee MJ, Rajabi AB, et al. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging. Ann Nucl Med. 2011 Feb;25(2):87-92.
5. Rasaneh S, Rajabi H, HBabaei M, Johari-Daha F. Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines. Appl Radiat Isot. 2010 Oct;68(10):1964-6.
6. Rasaneh S, Rajabi H, Babaei MH, Daha FJ. 177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer. Nucl Med Biol. 2010 Nov;37(8):949-55.
7. Raeisi E, Firoozabadi SM, Hajizadeh S, Rajabi H, Hassan ZM. The effect of high-frequency electric pulses on tumor blood flow in vivo. J Membr Biol. 2010 Jul;236(1):163-6.
8. Rasaneh S, Rajabi H, HBabaei M, Johari-Daha F. Synthesis and biodistribution studiesof 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model. J LABELLED COMPD RAD. 2010 Jul;53(6):575-9.
9. Shalchian B, Rajabi H, Soltanian-Zadeh H. Fusion of PET and CT images using wavelet transform. Hell J Nucl Med. 2009 Sep;12(3):238-43.
10. Rasaneh S, Rajabi H, Babaei MH, Daha FJ, Salouti M. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer. Nucl Med Biol 2009 May;36(4):363-9.
11. Shalchian B, Rajabi H, Soltanian-Zadeh H. Assessment of the Wavelet Transform in Reduction of Noise from Simulated PET J Nucl Med Technol. 2009 Dec;37(4):223-8.
12. Bitarafan-Rajabi A, Rajabi H, Rastgou F, Sharafi AA. Effect of respiratory motion on quantitative myocardial gated SPECT: a simulation study. Ann Nucl Med. 2009 Aug;23(6):587-93.
13. Salouti M, Rajabi H, Babaei MH, Rasaee MJ. Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical. Nucl Med Biol. 2008 Oct;35(7):763-8.
14. Bitarafan A, Rajabi H. The effect of filtrating and reconstruction method on the left ventricular ejection fraction derived from GSPET: a statistical comparison of angiography and echocardiography. Ann Nucl Med. 2008 Oct;22(8):707-13.
15. Kalantari F, Rajabi H, Yaghoobi N. Optimized energy window configuration for 201Tl imaging. J Nucl Med Technol. 2008 Mar;36(1):36-43.
16. Bitarafan A, Rajabi H, Gruy B, Rustgou F, Sharafi AA, Firoozabady H, et al. Respiratory motion detection and correction in ECG-gated SPECT: a new approach. Korean J Radiol. 2008 Dec;9(6):490-7.
17. Raeisi E, Rajabi H, Aghamiri SMR. A new approach for quantitative evaluation of reconstruction algorithm. Iranian Journal of Radiation Research. 2007 Sep;4(2):77-80.
18. Salouti M, RajabiI H, Babaei MH, Rasaee MJ, Najafi R, Paknejad M, et al. A new monoclonal antibody radiopharmaceutical for radioimmunoscintigraphy of breast cancer: direct labeling of antibody and its quality control. Daru. 2006 Mar;14(1):51-6.
19. Rasaneh S, Rajabi H, Hajizade E. Alternative methods for evaluation of non-uniformity in nuclear medicine images. I J Rad Res. 2005 Sep;3(2):89-94.
20. Rajabi H, Bitarafan A, Yaghoobi N, Firouzabadi H, Rustgou F. Determination of the Optimum Filter Function for Tc99m- -Sastamibi Myocardial Perfusion SPECT Imaging. IJNM. 2005;20(3):77-83.
21. Rajabi H, Pant GS, Padhy AK. Renal Transit times usinh modified method of deconvolutionne. IJNM. 2003;18(1):37-43.
22. Rajabi H, Pant GS, Padhy AK. Physical Validation of deconvolution software. IJNM. 2002;17(1):30-4.
23. Rajabi H, pant GS. Optimum filtration for time activity curve in nuclear medicine. Nucl Med Commun. 2000 Sep;21(9):823-9.
24. Rajabi H, Pant. GS. Optimum filtration for time-activity curves in nuclear medicine. Nucl Med Commun. 2000 Sep;21(9):823-8.
25. Rajabi H, Pant GS. An algorithm for filtration of time activity curve. I Med Phys. 2000 Apr;25(2):75-8.
26. Rajabi H, Pant GS. Evaluation of transit time by deconvolution analysis in a radionuclide renogram. J Med Phys. 1997 Dec;22(4):178-81.
27. Goliaei B, Rajabi H, Rabbani A. Effects of hyperthermia on the colony-stimulating factor production by the lung. Int J Radiat Oncol Biol Phys. 1992;22(5):1029-33.